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Activation of Autoreactive B Cells by CpG dsDNA
ing autoantibody producing plasmablasts (Hannum etGregory A. Viglianti,1,* Christina M. Lau,1,3
al., 1996; Wang and Shlomchik, 1999; William et al.,Timothy M. Hanley,1,3 Benjamin A. Miko,1
2002). Thus they constitute a suitable prototype to studyMark J. Shlomchik,2 and Ann Marshak-Rothstein1
the events that lead to the activation of potentially auto-1Department of Microbiology
reactive peripheral B cells. In vitro, they proliferateBoston University School of Medicine
vigorously when bound through the BCR to immuneBoston, Massachusetts 02118
complexes (ICs) containing IgG2aa/j mAbs specific for2 Departments of Laboratory Medicine
autoantigens such as DNA, intact nucleosomes, or his-and Immunobiology
tones but not when bound by ICs containing IgG2aaYale University School of Medicine
complexed with proteins or carbohydrates (LeadbetterNew Haven, Connecticut 06520
et al., 2002).
One common feature of the stimulatory mAbs is that
they can complex with chromatin released into cultureSummary
fluids from dead cells to form multivalent DNA-con-
taining ICs (chromatin ICs). Supporting the idea thatThe proliferative response of autoreactive rheumatoid
DNA is an essential component of the antigen is thefactor (RF) B cells to mammalian chromatin-con-
finding that DNase I blocks the ability of these mAbstaining immune complexes (ICs) results from the se-
to stimulate AM14 B cells (Leadbetter et al., 2002). Inquential engagement of the B cell receptor (BCR) and
addition, stimulation by these ICs requires the Toll-likeToll-like receptor 9 (TLR9). We have used ICs con-
receptor (TLR) adaptor protein, MyD88, and is inhibitedstructed from anti-hapten antibodies and defined hap-
by agents that block TLR9 signaling, either by preventingtenated dsDNA fragments to determine the form of
endosome acidification or directly inhibiting TLR9mammalian DNA that mediates this process. Despite
(Leadbetter et al., 2002). Although TLR-9 is known totheir relatively low abundance in mammalian DNA, we
mediate responsiveness to hypomethylated CpG-con-found that inclusion of hypomethylated CpG motifs in
taining bacterial DNA (Bauer et al., 2001; Hemmi et al.,these ICs was necessary for effective activation. In
2000), mammalian DNA has not been considered anthe absence of antibody, the same fragments could
efficient ligand for TLR9 (Messina et al., 1991; Yamamotoefficiently stimulate low-affinity hapten-specific and
et al., 1992). How then can mammalian DNA be an essen-DNA-reactive 3H9 B cells, but not RF B cells. These
tial bioactive component of ICs that stimulate cellsresults extend the BCR/TLR9 coengagement para-
through TLR-9-mediated signaling? One possibility isdigm to a second major class of autoreactive B cells,
that coengagement of the BCR somehow relaxes thefurther confirm the critical role of the BCR in chromatin
stringency of TLR9 recognition for canonical CpG motifsligand delivery to TLR9, and implicate hypomethylated
and/or hypomethylated CpG dinucleotides (Wang andCpG motifs as ligand elements necessary for the initia-
Krieg, 2003). Another possibility is that the chromatintion of systemic autoimmune disease.
released into the culture fluids is particularly enriched
for hypomethylated CpG stretches of DNA. A better un-Introduction
derstanding of the mechanism by which chromatin ICs
stimulate B cells should provide important insights intoSystemic lupus erythematosus (SLE) and other autoim-
the initiation and propagation of systemic autoimmunitymune diseases are characterized by the production of
and, potentially, new therapeutic approaches. In this
antibodies specific for a relatively limited set of autoanti-
regard, there are two fundamental questions. First, is
gens (Plotz, 2003). DNA, chromatin-associated proteins,
signaling initiated through BCR crosslinking required,
ribonucleoproteins, and autologous IgG are among or is the BCR merely a conduit to deliver the TLR9 ligand
those molecules that consistently emerge as prime tar- to the appropriate intracellular compartment? Second,
gets in systemic diseases such as SLE and rheumatoid what is the true nature of the ligand?
arthritis, both in human patients and in animal models In order to better dissect the mechanisms responsible
(Cohen and Eisenberg, 1991; Kotzin, 1996). A number for this BCR/TLR9-dependent activation scheme, it is
of B cell receptor (BCR) transgenic (Tg) mouse lines have critical to identify the key properties of stimulatory li-
provided useful experimental tools to better understand gands, both in terms of their structural ability to stimulate
the factors that link these particular autoantigens to TLR9 as well as their capacity to crosslink the BCR.
disease. The MRL-lpr derived AM14 strain is one exam- Unfortunately, our attempts to subfractionate chromatin
ple (Hannum et al., 1996). AM14 rheumatoid factor (RF) and add it back to cultures containing chromatin-reac-
producing B cells recognize autologous IgG2a with rela- tive antibodies have inevitably been confounded by con-
tively low affinity. On a nonautoimmune prone genetic tinuously released chromatin of indeterminate size and
background, AM14 B cells persist in the periphery as composition from apoptotic cells. As an alternative
mature naive B cells, but on an autoimmune-prone Fas- strategy, we have now synthesized a series of defined
deficient background, they convert to actively proliferat- haptenated-dsDNA fragments that can be recognized
by IgG2aa/j mAbs, and compared the capacity of these
DNA fragment ICs and spontaneous chromatin ICs to*Correspondence: gviglian@bu.edu
3 These authors contributed equally to this work. bind and stimulate AM14 B cells. We find that only those
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ICs containing DNA with canonical hypomethylated CpG Protein ICs Stimulate High-Affinity RF B Cells
motifs can stimulate AM14 B cells. These fragments To prove that the protein ICs were sufficiently multiva-
have also proven to be a powerful tool for demonstrating lent to stimulate B cells with antigen binding constants
that chromatin IC stimulation includes an active role for that approach the standard affinity for foreign antigen,
the BCR in the signaling cascade. Finally, these same it was important to compare the proliferative responses
fragments have allowed us to directly test the relevance of the AM14 and 20.8.3 B cells stimulated by the various
of BCR/TLR9 coengagement to other BCR Tg models, configurations of IgG2a. B cells isolated from non-Tg and
including low-affinity NP/NIP-specific and 3H9 DNA- Tg mice were cultured for 2 days with Hy1.2 (monomeric
reactive lines. The results confirm the general applicabil- IgG2a), Hy1.2TNP-BSA (protein IC), or PL2-3 (chroma-
ity of our model to non-RF autoreactive B cells. Together tin IC), and proliferation was assessed by 3H-thymidine
these data indicate that hypomethylated CpG motifs incorporation (Figure 1B). Even though monomeric
in mammalian DNA play an important role in systemic Hy1.2 bound to the 20.8.3 cells quite effectively, it failed
autoimmune diseases, and suggest that environmental to stimulate either AM14 or 20.8.3 B cells to proliferate.
and genetic factors that increase the availability of this By contrast, protein ICs that failed to activate AM14 B
material to the immune system can contribute to dis- cells were found to activate 20.8.3 cells remarkably well,
ease onset. especially when compared to a standard F(ab)’2 anti-
IgM reagent. Nevertheless, chromatin IC stimulated the
Results 20.8.3 cells much more effectively than protein IC; 0.01
g/ml of chromatin IC IgG2a induced the same level of
Binding of Monomeric and Multimeric IgG2a proliferation as 1.0 g/ml of protein IC IgG2a. These
to IgG2a-Specific B Cells results demonstrate that even though monomeric IgG2a
AM14 B cells proliferate vigorously in response to chro- and the protein IC bind comparably to the 20.8.3 B cells,
matin ICs that spontaneously form between chromatin- a proliferative response can only be induced by a form
reactive mAbs, such as PL2-3, and DNase 1 sensitive of the antigen that can effectively crosslink the B cell
antigens present in “spent” culture media. In contrast, receptor. Moreover, the nature of the antigen in the ICs
protein ICs formed between anti-hapten mAbs, such as is critical even with the higher affinity receptor, as chro-
Hy1.2, and haptenated proteins, such as TNP-BSA, fail matin ICs stimulate 100-fold more effectively than pro-
to stimulate AM14 B cell proliferation (Leadbetter et tein ICs. FcRII-deficient 20.8.3 B cells responded to
al., 2002). One possible explanation for this apparent both protein and chromatin ICs to a similar extent as
disparity is that the protein ICs simply bind to AM14 the FcRII-sufficient 20.8.3 B cells, demonstrating that
B cells less efficiently than the chromatin ICs, due to stimulation by these ICs is not adversely affected by
differences in the overall size and/or configuration of engagement of the FcRII.
the two types of complexes. To address this issue, we
compared the binding of monomeric mAb (PL2-3  me- Construction of Defined DNA ICs
dium or Hy1.2  medium), preformed chromatin IC These data demonstrate that chromatin ICs provide a
(PL2-3 preincubated with spent culture supernatants),
remarkably potent stimulus for both low-affinity and
and protein IC (Hy1.2  TNP-BSA) to either non-Tg,
high- affinity IgG2a-specific B cells. One question raised
AM14 Tg, or 20.8.3 Tg B cells (Wang and Shlomchik,
by these observations is whether there is anything1997) (Figure 1A). The BCRs expressed by both Tg lines
unique about the chromatin present in the culture fluids,recognize IgG2aa/j antibodies; however AM14 was de-
presumably released from apoptotic cells, which mightrived from a mouse with systemic autoimmune disease
distinguish it from mammalian chromatin purified fromand the 20.8.3 line was derived from a mouse immunized
intact live cells. To begin this analysis, DNA purified fromwith allotype-disparate IgG2a. AM14 binds IgG2a with
the supernatants of cultured total MRL/ spleen cellsa binding constant (Kd  1.7  106) typical of the RF
was separated by gel electrophoresis and resolved intoantibodies isolated from an MRL/lpr mouse (Jacobson
a DNA ladder characteristic of internucleosomal cleav-et al., 1994), while 20.8.3 binds IgG2a with an affinity
age during apoptosis. The chromatin fragments rangedthat is 2 to 3 logs higher than that of the AM14 receptor
in size from 146 bp mononucleosomes to polynucleo-(unpublished data; Wang and Shlomchik, 1997). As
somes greater than 10 kb in length (Figure 1C). Basedmight be expected, AM14 cells bound monomeric IgG2a
on the intensity of ethidium bromide staining relative toonly slightly better than non-Tg cells, while both the
DNA standards, we estimated that the cell-free superna-protein ICs and chromatin ICs bound quite effectively.
tant contained approximately 5 g/ml of DNA. We ini-By comparison, the higher affinity 20.8.3 cells bound
tially attempted to compare the immunostimulatory ac-the monomeric mAbs almost as well as the ICs. Notably,
tivities of chromatin prepared from various sources butas measured by mean fluorescent intensity, the protein
found that this approach was limited by the high back-IC and chromatin IC bound AM14 and 20.8.3 cells to a
ground resulting from the continuous release of apo-comparable extent, suggesting that the great differ-
ptotic chromatin from the responder population. Weences in their stimulatory capacity for AM14 B cells is
therefore switched to a strategy that involved the syn-not attributable to differences in their ability to bind the
thesis of double-stranded DNA products that could beBCR on these cells. These staining data indicate that
haptenated and then bound by monoclonal IgG2aa anti-chromatin IC and protein IC form multivalent antigens
hapten antibodies.that bind much more avidly to the low-affinity AM14
We isolated a 660 bp EcoRI/BamHI DNA restrictionreceptor than monomeric IgG2a; however, multivalency
is much less essential for the 20.8.3 receptor. fragment containing an array of 50 CpG motifs from the
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Figure 1. Chromatin-Containing but Not Protein-Containing Immune Complexes Stimulate AM14 B Cells
(A) The anti-nucleosome mAb, PL2-3, or the anti-TNP mAb, Hy1.2, were added either alone or as preformed ICs (PL2-3 spent cell supernatant;
Hy1.2  TNP-BSA [4:1 mass ratio]) to either wild-type, low-affinity RF (AM14), or high-affinity RF (20.8.3) splenic B cells. Antibody/IC binding
to B cells from WT, AM14, or 20.8.3 mice was detected by staining for both IgG2a and B220.
(B) Proliferation of wild-type, AM14, 20.8.3, and 20.8.3 FcRII-deficient B cells in response to varying concentrations of anti-IgM F(ab)2, anti-
nucleosome (PL2-3), or anti-TNP (Hy1.2) mAbs, or anti-TNP/TNP-BSA ICs (Hy1.2/TNP-BSA).
(C) Chromatin content of splenic B cell culture supernatants (size standards, lanes 1 and 2; chromatin-associated DNA, lane 3).
plasmid pMCG50 (Krieg et al., 1998). The CpG dinucleo- to the other end, resulting in NIP2-CG50-NIP. These
fragments were mixed with the anti-NIP mAb, 23, totides in this fragment, referred to as CG50, are in an
optimal sequence context (GACGTT) to activate murine form DNA-fragment ICs.
TLR9. The overhanging 5 ends of the CG50 fragment
were repaired with Klenow polymerase in the presence Hapten-DNA-Fragment ICs Stimulate AM14
B Cells by a TLR9-Dependent Pathwayof 5-(3-aminoallyl)-dUTP (aa-dUTP) and the amine
groups on the incorporated aa-dUTP residues were de- We found that anti-NIP/NIP2-CG50-NIP ICs stimulated
AM14 B cell proliferation and that proliferation was de-rivatized using succinimidyl ester conjugated nitroiodo-
phenyl (NIP). This procedure added 2 NIP hapten groups pendent on the concentration of both the mAb and the
NIP-DNA (Figure 2A). Neither the DNA nor the mAb aloneto one end of the fragment and 1 NIP hapten group
Immunity
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Figure 2. DNA Fragment Immune Complexes Stimulate AM14 B Cells through a TLR-Dependent Mechanism
(A) Proliferation of AM14 B cells in response to ICs formed between varying concentrations of a NIP-conjugated DNA fragment containing 50
immunostimulatory CpG motifs (CG50) and the anti-NIP mAb, 23.
(B) Proliferation of AM14 B cells in response to ICs formed between unconjugated or NIP- or TNP-conjugated CG50 and either the anti-TNP
mAb, Hy1.2 (left), or the anti-NIP mAb, 23 (right).
(C) Proliferation of AM14 B cells preincubated for 1 hr with the inhibitory CpG sODN 2088 (4 g/ml) before the addition of either the stimulatory
sODN 1826 (1 g/ml), PL2-3 mAb, or Hy1.2 mAb and TNP-conjugated CG50 (250 ng/ml). The ability of the various ligands to stimulate
proliferation of AM14 B cells was compared with the stimulation induced by anti-IgM F(ab)2.
(D) Proliferation of AM14 B cells from either MyD88/ or MyD88/ mice that were stimulated with sODN 1826, or PL2-3, or Hy1.2/TNP2-
CG50-TNP ICs.
could effectively stimulate proliferation, showing that MyD88/ B cells. DNA fragment ICs were potent activa-
tors of the MyD88/ cells but they failed to activate thethe immunostimulatory activity of the ICs was not due
to either monovalent antibody-dependent signaling MyD88/ cells (Figure 2d). The MyD88/ cells also
failed to respond to either sODN 1826 or to PL2-3/chro-through the BCR or endotoxin contamination of either
of the reagents. Moreover, NIP2-CG50-NIP failed to matin ICs. As expected, they responded normally to
anti-IgM F(ab)2 fragments, indicating that their abilitystimulate B cell proliferation when combined with the
anti-TNP mAb, Hy1.2, even though Hy1.2/TNP2-CG50- to proliferate in response to BCR crosslinking was not
impaired.TNP ICs stimulated very effectively. These data indicate
that independent engagement of the BCR does not aug-
ment the immunostimulatory activity of uncomplexed DNA Fragment ICs Can Stimulate without Extensive
Crosslinking of the BCRDNA fragments (Figure 2B).
To determine whether DNA fragment ICs actually acti- Together the above experiments demonstrate that BCR-
mediated uptake of DNA fragments that would other-vate through TLR9, we stimulated AM14 B cells either
in the presence or absence of the TLR9 inhibitory oligo- wise remain extracellular facilitates stimulation of AM14
B cells in a TLR9-dependent fashion. However, the exactdeoxynucleotide (sODN) 2088 (Krieg et al., 1998). We
found that sODN 2088 inhibited DNA fragment IC- role of the BCR in this process is unclear. Does the BCR
simply serve as a shuttle between the plasma membraneinduced proliferation by 80%, similar to the level of
inhibition obtained when the cells were stimulated with and TLR9, or does crosslinking of the BCR actually con-
tribute to the activation process? Although the CG50PL2-3/chromatin ICs (Figure 2c). As expected, 2088 in-
hibited the response to the immunostimulatory CpG fragment could at most have a coupling ratio of 3 hapten
groups/molecule, in theory it should still be possible tosODN, 1826, and had no effect on the response to cross-
linking of the BCR by anti-IgM (Leadbetter et al., 2002; form multivalent complexes. To examine the role of BCR
crosslinking more rigorously, we prepared CG50 frag-data not shown). We also asked whether MyD88 was
required for the response to these fragment ICs by com- ments conjugated at only one end with a single TNP
group (TNP-CG50). The stimulatory activity of the mono-paring the responses of AM14 MyD88/ and AM14
Autoreactive B Cell Activation by CpG dsDNA
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Figure 3. Monohaptenated DNA Fragment Immune Complexes Stimulate AM14 B Cells
(A) Proliferation of AM14 B cells in response to ICs formed between Hy1.2 and varying concentrations of TNP-conjugated CG50 DNA fragments
containing either a single (TNP-CG50) or three (TNP2-CG50-TNP) hapten groups.
(B) Binding of preformed chromatin ICs (PL2-3  spent cell supernatant), monomeric IgG2a (Hy1.2  media), protein ICs (Hy1.2  TNP-BSA),
and DNA fragment ICs (Hy1.2  TNP2-CG50-TNP or Hy1.2  TNP-CG50; each containing 250 ng/ml DNA), to AM14 B cells detected by
staining for both IgG2a and B220.
substituted CG50 was then compared to the trisubsti- 25 CpG dinucleotides, 12 of which are flanked by a 5
C or a 3 G and are therefore predicted to be eithertuted CG50 described above (TNP2-CG50-TNP). We
reasoned that if crosslinking of the BCR were required, poorly immunostimulatory or perhaps inhibitory [TNP2-
HIV(CG)-TNP]; and (3) a 629 bp fragment derived fromthen the activity of the TNP-CG50 fragment ICs should
be substantially less than that of the TNP2-CG50-TNP the HIV-1 gag gene that contained no CpG dinucleotides
[TNP2-HIV(CG–)-TNP]. Only the CG50 fragments in-fragment ICs. However, we found that the mono- and tri-
substituted fragments elicited comparable responses duced a strong proliferative response (Figure 4A). Al-
though ICs formed with both of the HIV-1-derived DNAs(Figure 3A), consistent with the premise that BCR cross-
linking is not required for BCR-mediated enhancement induced modest AM14 B cell proliferation at high con-
centrations, they were at least 100-fold less active thanof proliferation by these ligands.
Moreover, flow cytometry showed that both the mono- the fragment containing canonical CpG motifs. These
findings demonstrate that sequence is a critical factorsubstituted and the trisubstituted fragment ICs were
inefficiently bound by the low-affinity AM14 B cells, sug- with regard to the stimulatory capacity of both fragment
ICs and chromatin IC.gesting that neither was likely to induce extensive recep-
tor crosslinking (Figure 3B). In the same experiment, The CG50 fragments were isolated from plasmids
grown in a dam–/dcm– strain of E. coli and all the cyto-comparable levels of IgG2a incorporated into either
chromatin ICs or protein ICs were much more effectively sines and adenosines were therefore unmethylated. To
determine whether hypomethylation was necessary forbound by these B cells. These data indicated that the
DNA component of the fragment ICs was a more impor- stimulatory activity, we methylated the TNP2-CG50-TNP
fragment in vitro with the CpG methylase, SssI. Thistant determinant of their stimulatory activity than their
ability to crosslink the BCR. However, we did consis- procedure effectively eliminated hypomethylated CpGs,
as shown by the complete resistance of these fragmentstently find that “natural” chromatin ICs were approxi-
mately 2- to 5-fold more stimulatory than the DNA frag- to the restriction endonuclease HpyCH4IV (Figure 4B).
We found that methylation of the fragment completelyment ICs (Figure 2C); the difference may reflect the
contribution of BCR-initiated signaling events that are blocked its ability to stimulate proliferation (Figure 4B).
This finding confirms that hypomethylated, CpG-con-a consequence of a higher valency of the chromatin ICs.
taining DNAs are a necessary component of the immu-
nostimulatory DNA fragment ICs. Importantly, the HIV-1DNA Sequence and Methylation Are Critical Factors
and CG50 DNA fragment ICs all bound to AM14 B cellsin Fragment IC Activation
equivalently, indicating that differences in their immuno-Given the paramount role of the DNA component, it
stimulatory activity were not due to differences in theirwas important to determine whether the DNA sequence
ability to bind to the BCR (Figure 4C).contributed to the stimulatory capacity of the fragment
Since we found that anti-hapten mAbs could augmentIC. To evaluate the role of CpG motifs, we compared
the immunostimulatory activity of haptenated CG50the activities of ICs formed with three different TNP-
DNA fragments, we asked whether they could also aug-haptenated DNAs. These included either (1) the 660 bp
ment the activity of haptenated, restriction enzyme di-TNP2-CG50-TNP fragment; (2) a 726 bp fragment de-
rived from the promoter region of HIV-1 that contained gested murine DNA. We found that ICs formed between
Immunity
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Figure 4. DNA Sequence and Methylation Are Critical Factors in DNA Fragment Immune Complex Activation of AM14 B Cells
Proliferation of AM14 B cells in response to ICs formed between Hy1.2 and varying concentrations of either TNP-conjugated CG50 DNA
(TNP2-CG50-TNP), a TNP-conjugated DNA fragment containing 25 noncanonical CpG motifs (TNP2-HIV(CG)-TNP), or a TNP-conjugated
DNA fragment lacking CpG dinucleotides (TNP2-HIV(CG-)-TNP). (B) Digestion of unmethylated or in vitro methylated (SssI) TNP-conjugated
CG50 DNA with the methylation sensitive restriction endonuclease, HpyCH4 IV (top). Proliferation of AM14 B cells in response to ICs formed
between Hy1.2 and varying concentrations of either unmethylated or methylated TNP-conjugated CG50 DNA (bottom). (C) Binding of 32-P
labeled TNP-conjugated DNA fragments (250 ng/ml) to either AM14 RF or RF B cells either alone or as ICs with the anti-TNP mAb, Hy1.2.
(D) Proliferation of AM14 B cells in response to undigested (UN), DdeI digested (RE), or DdeI digested and TNP-conjugated mouse or E. coli
DNA (RE TNP) (all at 250 ng/ml), either alone (-Ab) or as ICs with Hy1.2 (Ab) was measured by 3H-thymidine incorporation.
TNP-conjugated, DdeI digested mouse genomic DNA two additional Tg mouse lines. These mice, VH186.2
and VH186.2L, express heavy chain Tgs that pair withfragments and Hy1.2 stimulated AM14 B cell prolifera-
tion approximately 10-fold above the media control. In endogenous  chains to form NIP/NP-specific receptors
of medium or low affinity, respectively. Similar to ourcontrast, similar ICs formed using E. coli DNA fragments
stimulated proliferation approximately 160-fold (Figure findings with AM14 B cells, we found that splenic B
cells from both VH186.2 and VH186.2L proliferated in4D). Importantly, neither mouse nor E. coli DNAs at the
concentrations used (250 ng/ml) were active in the ab- response to NIP2-CG50-NIP fragments but not to NIP-
BSA (Figure 5A). It therefore appears that low-affinitysence of antibody. These results indicate that mouse
genomic DNA is only weakly immunostimulatory even hapten-specific B cells can also be induced to prolifer-
ate by antigens capable of engaging TLR9. Thus stimula-when it is taken up by cells via the BCR and suggest
that certain features of apoptotic chromatin must render tion of B cells by BCR-mediated TLR9 ligand delivery
is a general mechanism not limited to autoreactive spec-this form of autoantigen particularly immunogenic.
ificities such as RF.
DNA Fragments Can Activate Low-Affinity
B Cells Directly Fragment ICs Stimulate B Cells from 3H9
DNA-Reactive B CellsTo determine whether low-affinity B cells, other than
AM14 B cells, can be activated by the haptenated CG50 The ability of DNA fragments to so effectively promote
the activation of AM14 IgG2a B cells as well as NIP-DNA fragment, we examined its effect on B cells from
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3H9 cultures was consistently higher than that observed
with either the VH186.2 or AM14 B cells; background
proliferation was also reduced in the chloroquine and
sODN 2088 cultures. This elevated background is pre-
sumably due to direct stimulation of chromatin-reactive
cells in the population by the chromatin present in the
spent culture fluid. These results extend the BCR/TLR9
paradigm to the activation of DNA reactive B cells.
Stimulation of B Cells by DNA-Containing ICs
Can Be Blocked by Cyclosporin A
The above studies established a critical role for the BCR
in the transport of autoantigen to TLR9. However, they
did not address the potential contribution of BCR en-
gagement to the signaling cascade that leads to AM14
or 3H9 proliferation. Cyclosporin A (CsA) has been
shown to prevent the BCR crosslinking-induced activa-
tion of NFAT required for cellular proliferation (Dong-
worth and Klaus, 1982; Rui et al., 2003). Consistent with
this finding, CsA blocked the AM14 B cell response to
anti-IgM F(ab)2 crosslinking by 96% and had abso-
lutely no effect on the AM14 B cell response to CpG
1826 (Figure 6A). If the BCR served only as a conduit
to TLR9 in the chromatin and/or fragment IC-stimulation
of AM14 cells, then that response should be unaffected
by CsA. However, CsA consistently blocked the AM14
response to chromatin ICs by 60%–80% and blocked
the AM14 response to the fragment ICs by 40%–50%.
Chromatin ICs bind more avidly to AM14 B cells than
fragment ICs (Figure 3B) and have a lower frequency of
CpG motifs than the fragment ICs. Therefore it is not
surprising that the AM14 response to chromatin ICs is
somewhat more sensitive to CsA than the response to
fragment ICs.
A similar pattern was observed with the fragment-
reactive cells present in the 3H9 population. CsA com-
pletely blocked the response of 3H9 B cells to anti-IgM
crosslinking, had little to no effect on the 3H9 response
to CpG 1826, or the lipopeptide Pam3Cys, but blocked
the 3H9 response to CG50 by approximately 60% (Figure
6B). Together, these data indicate that the AM14 re-
Figure 5. CG50 DNA Fragments Efficiently Stimulate Low-Affinity sponse to ICs containing either mammalian DNA or de-
Hapten-Specific and DNA-Reactive B Cells fined DNA fragments results from signals emanating
(A) Low-affinity (VH186.2L) (1 of 2 comparable experiments) and from both TLR9 and the BCR. However, the contribution
moderate-affinity (VH186.2) (two of three comparable experiments) of the BCR to signaling events can vary depending on
hapten-reactive B cells were stimulated with varying concentrations
the extent of BCR crosslinking and the density ofof NIP2-CG50-NIP or NIP-BSA.
CpG motifs.(B) 3H9 B cells were stimulated with varying concentrations of the
DNA fragments CG50, HIV-(CG), and HIV-(CG-).
(C) 3H9 B cells were stimulated with varying concentrations of CG50 Discussion
in the presence or absence of sODN 2088 or chloroquine.
We previously reported that ICs formed between IgG2aa
mAbs and apoptotically released chromatin, present inspecific B cells raised the possibility that a similar TLR9-
dependent process could be involved in the activation spent culture supernatants, induced the TLR9-depen-
dent proliferation of AM14 IgG2a-reactive RF B cells.of DNA-reactive B cells. To test this possibility, we iso-
lated B cells from anti-DNA 3H9 Tg mice and cultured However a number of key issues pertaining to the actual
mechanism of chromatin IC-mediated activation ofthem with CG50, HIV(CG), and HIV(CG-) fragments.
Proliferation was observed only in the CG50 stimulated AM14 B cells were left unresolved. The first question
was the actual composition of the chromatin portion ofcultures (Figure 5B). To determine whether this response
was TLR9 dependent, the 3H9 cells were stimulated the IC ligand. Vertebrate DNA is generally considered a
poor activator of TLR9 compared to its putative naturalwith CG50 in the presence of either chloroquine or sODN
2088, two inhibitors of the TLR9 signaling pathway. Both ligand, hypomethylated CpG-containing bacterial DNA.
Moreover, naked vertebrate genomic DNA, even whenchloroquine and sODN blocked the response of the 3H9
cells to CG50 (Figure 5C). Notably, the level of spontane- extensively demethylated, does not activate B cells and
can actually inhibit activation by bacterial DNA (Kriegous proliferation (in the absence of fragments) in the
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Figure 6. Cyclosporin A Partially Blocks the
Proliferation of Autoreactive B Cells Stimu-
lated by Chromatin or DNA Fragment IC
(A) AM14 B cells were stimulated with anti-
IgM F(ab’)2, sODN 1826, PL2-3, or DNA-frag-
ment ICs in the presence of 1-100 ng/ml CsA.
(B) 3H9 B cells were stimulated with anti-IgM
F(ab)2, sODN 1826 (1 g/ml), Pam3Cys (10
g/ml), or CG50 (250 ng/ml) in the presence
of 1–100 ng/ml CsA. Data are representative
of 5 (A) and 2 (B) independent experiments
and are presented as the percentage of the
response to the same stimuli in the absence
of CsA. Total 3H-thymidine incorporation
(cpm) obtained in the absence of CsA for (a)
are anti-IgM F(ab)2 (80,000), sODN 1826
(168,000), PL2-3 (137,000), or DNA-fragment
ICs (134,000) and for (b) are anti-IgM F(ab)2
(168,000), sODN 1826 (372,000), Pam3Cys
(372,000), or CG50 (111,000).
et al., 1995; Messina et al., 1991). One explanation for et al., 2003). Although short synthetic sODNs such as
CpG 1826 appear to reach TLR9 without an antibodythe poor stimulatory activity of mammalian DNA is the
low frequency of CG dinucleotides. CpG motifs are escort, it seems that the BCR is absolutely required to
direct conventional dsDNA fragments to the appropriatefound in vertebrate genomes at approximately one
fourth of the expected random rate and those that are endosome/lysosome compartment where TLR9 is sub-
sequently engaged (Ahmad-Nejad et al., 2002). Notably,present tend to be methylated and flanked by a 5 C
residue and a 3 G residue (Karlin et al., 1994), a se- higher concentrations of E. coli DNA have been shown
to activate B cells in the absence of such an antibody-quence context that is poorly immunostimulatory (Krieg,
2002). In addition, mammalian DNA may contain regions dependent shuttle mechanism (Messina et al., 1991;
Krieg, 2002).that specifically block TLR9 activation (Lenart et al.,
2001). Therefore, the link between mammalian DNA, Others have found that the stimulatory activity of
mammalian DNA can be markedly enhanced by trans-TLR9, CpG motifs, and the activation of autoreactive B
cells, established by this report, is quite remarkable. fection protocols that deliver DNA to the cytoplasm (Ishii
et al., 2001; Zhu et al., 2003). Whether this effect is dueHow is it then that mammalian chromatin becomes
such an effective ligand in the context of BCR-mediated to enhancement of the overall level of uptake, selective
targeting to a particular cellular location, or artifactsdelivery to TLR9? The data do not support a mechanism
involving loss of TLR9 stringency for CpG motifs (Wang resulting from the transfection procedure is still unclear.
Transfection of macrophages or dendritic cells withand Krieg, 2003). A more likely explanation is that apo-
ptotic chromatin is enriched in hypomethylated stimula- mammalian DNA or synthetic polydeoxynucleotides can
induce the increased expression of both MHC class I andtory CpG motifs. The mouse genome is estimated to
contain approximately 37,000 CpG islands that include class II molecules as well as various proteins involved in
antigen processing and costimulation. For the most part,clusters of hypomethylated CpG dinucleotides (Cross
et al., 1997). These islands are primarily found in the these affects appear to be independent of both DNA
sequence and CpG methylation status (Ishii et al., 2001;promoter regions of genes (Cross and Bird, 1995; Gardi-
ner-Garden and Frommer, 1987) and may be preferen- Zhu et al., 2003). However, only unmethylated bacterial
DNA could induce these same cells to make the cyto-tially released by the nucleases activated during apopto-
sis (Krystosek, 1999). The chromatin present in culture kines IL-6 and IL-12. By comparison, our findings dem-
onstrate that DNA sequence and CpG methylation arefluids may therefore be dramatically enriched in CpG
DNA. Notably, anti-DNA/DNA ICs isolated from the se- critical factors in the ability of the DNA fragment ICs
to activate AM14 B cell proliferation. The most likelyrum of SLE patients have been found to have higher GC
content than total human DNA (Sano and Morimoto, explanation for these differences is that the transfected
DNAs are at least partially activating the cells through1982).
Another possible explanation is that unselected mam- a TLR9-independent pathway. The roles of sequence
and methylation status have also been examined in ex-malian DNA may have sufficient CpG content to activate
B cells as long as it is efficiently delivered to a TLR9- perimental models involving the coactivation of B cells
by synthetic ODN and suboptimal concentrations of BCRcontaining compartment. Our data on mammalian
genomic DNA fragment ICs (Figure 4D) discount this ligands. In some experiments, only hypomethylated
CpG ODN appear to synergize with BCR ligands (Kriegpossibility. However, the importance of delivery was em-
phasized by the complete inability of either CG50 frag- et al., 1995), while in others, methylated CpG or even
non-CpG ODN can effectively costimulate B cells (Goeck-ments or relatively low concentrations of E. coli DNA
fragments to activate AM14 B cells in the absence of a eritz et al., 1999; Wang and Krieg, 2003). It will be impor-
tant to determine the role of TLR9 in these particular“shuttle” antibody, despite their high content of stimula-
tory CpG motifs. TLR9 is sequestered away from the protocols, by using TLR9 specific inhibitors or appropri-
ately gene-targeted cell populations.plasma membrane in a cytoplasmic compartment (Heit
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Our findings further indicate that DNA fragment ICs for AM14 cells applies directly to such chromatin-reac-
can activate B cell proliferation in the apparent absence tive B cells.
of BCR crosslinking. Monohaptenated DNA fragment The original 3H9 hybridoma cell line was derived from
ICs stimulated AM14 B cells as well as trihaptenated a diseased MRL/lpr mouse as an IgG2a/V	4 DNA-reac-
fragment ICs. Moreover, binding of the DNA fragment tive antibody (Shlomchik et al., 1987). It was subse-
ICs to AM14 B cells was barely detectable by flow cy- quently shown that the 3H9 heavy chain can pair with
tometry, in contrast to the enhanced binding observed a variety of endogenous light chains to generate anti-
for multivalent IgG2a protein and chromatin ICs. Studies bodies reactive with both single-stranded and double-
from Pierce and colleagues have indicated that the BCR stranded DNA (Radic et al., 1991). 3H9 ssDNA-reactive
continuously cycles from the cell surface to the peptide antibodies can be isolated from hybridoma cell lines
loading compartment, even in the absence of receptor derived from nonautoimmune prone 3H9 Tg mice (Roark
crosslinking (Song et al., 1995), and it is reasonable to et al., 1995). Moreover, wild-type mice also contain
assume that a similar process may mediate the transport dsDNA-reactive 3H9 B cells that can be detected at
of DNA fragments from outside the cell to the TLR9- the T/B interface of the spleen by immunofluorescence
associated compartment. However, in the case of con- (Mandik-Nayak et al., 1997). Thus it is reasonable to
ventional foreign proteins, this mode of antigen inter- assume that low-affinity DNA-reactive B cells are pres-
nalization is not sufficient to induce proliferation, as ent in the normal repertoire of B6 3H9 heavy chain only
documented in the current report by the failure of mono- mice. It was therefore not surprising that B cells from
meric IgG2a to stimulate even the high-affinity 20.8.3 B B6 3H9 heavy chain Tg mice can be stimulated robustly
cells to proliferate. by the same nonhaptenated CG50 fragments that com-
The inhibitory effect of CsA on the AM14 response to pletely failed to stimulate AM14 B cells. 3H9 H Tg mice
both chromatin and fragment ICs, but not direct TLR also have anergic dsDNA-reactive B cells. It is not clear
ligands, suggests that the BCR serves as more than just whether these, too, can be stimulated to proliferate by
a conduit, and in some way contributes to the signaling BCR/TLR9 cosignals; if so, this would be another mech-
cascade. It appears that the contribution of the BCR to anism of breaking tolerance. Studies are in progress to
the activation process can vary depending on the extent further characterize the 3H9 CG50 reactive cells and to
of BCR engagement and the density of CpG motifs. confirm the importance of TLR9 to the in vivo develop-
Chromatin ICs bind more avidly to AM14 B cells than ment of systemic disease.
fragment ICs (Figure 3B), and have a lower frequency
of CpG motifs. Therefore it is not surprising that the
Experimental ProceduresAM14 response to chromatin ICs is somewhat more
sensitive to CsA than the response to fragment ICs. Mice
Therefore, we propose that chromatin ICs generate two AM14 RF and RF– littermates were obtained from crosses between
independent signals when they bind to AM14 B cells: a MRL or Balb/c AM14 H chain and MRL V	8 light chain Tg mice. The
high-affinity IgG2a-reactive 20.8.3 mice and 20.8.3 FcRII/ werepartial signal through IgG2a engagement of the low-
identified by PCR as described previously (Wang and Shlomchik,affinity BCR and a suboptimal TLR9 signal mediated by
1997). The anti-NP Tg line VH186.2 (previously referred to asthe relatively sparse hypomethylated CpG motifs. The
(ms)Ig-Tg) has been described previously (Hannum et al., 2000).
strong proliferative response of the B cells therefore VH186.2L was made with a similar construct, except that the Vh
results from the combined signals generated from both region was recovered from a GC cell that had 3 mutations in the
the BCR and TLR9, and possibly other receptors such Vh. One of these resulted in a glycine replacement of histidine at
codon 50 that in turn resulted in an20-fold reduction in the affinityas cellular DNA or nucleosome receptors. This synergy
for NP (Dal Porto et al., 1998, 2002). B6 mice expressing the 3H9may reflect sequential events that begin at the plasma
heavy chain transgene were generously provided by Drs. E. Paulmembrane and then further develop at the endosome/
and M. Carroll (Harvard Medical School).lysosome membrane. Alternatively, the BCR and TLR9
may physically interact at the membrane of the TLR9-
mAbsassociated compartment. The demonstration that hap-
Monoclonal IgG2a antibodies specific for nucleosome (PL2-3)ten-conjugated CG50 DNA fragments can directly stimu-
(Monestier and Novick, 1996), TNP (Hy1.2) (Hannum et al., 2000), orlate both moderate and low-affinity NP-specific B cells
NP/NIP (23) (Wolfowicz et al., 1988) were affinity purified underunder conditions where NP-BSA does not, further sup-
sterile conditions and determined to be endotoxin free using
ports our premise that BCR/TLR9 coengagement is a the Limulus amebocyte lysate assay (BioWhittaker) (less than 0.3
generally effective mechanism for the activation of low EU/ml).
affinity B cells. It also raises the possibility that this is
a general mechanism for foreign antigen responses in
Plasmids
vivo, in situations involving opsinized or intracellular The plasmid pMCG-50, containing 50 copies of a murine CpG immu-
bacteria. nostimulatory sequence, was provided by Dr. A. Krieg (Coley Phar-
AM14 B cells have served as a useful prototype for maceuticals). The murine CpG sequences were subcloned into pLIT-
low-affinity RF B cells, and have provided a framework MUS-29 to form pLIT-CG50.1. An HIV-1 sequence containing 25
CpG dinucleotides (nucleotides 112-838 of pNL4-3) predicted tofor understanding the connection between chromatin-
be nonimmunostimulatory was also subcloned into pLITMUS-29 toassociated autoantigens and TLR9. However, in the
form pLIT-HIV(CG). An HIV-1 sequence free of CpG dinucleotidescontext of systemic disease, chromatin-specific autoan-
(nucleotides 931-1560 of pNL4-3) was cloned into pUC18 to form
tibodies are needed before it is possible to form chroma- pUC-HIV(CG-). The DNA fragments contained in these plasmids
tin-containing ICs, and such antibodies, of necessity, were all flanked by an EcoRI site on one end and a BamHI site on
come from chromatin-reactive B cells. A major insight the other end. All plasmids were propagated in the dam/dcm E.
coli strain GM2163.from the current report is that the principle established
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Hapten-Conjugated DNA Fragments RF control B cells were incubated with the DNAs either alone or
as ICs with the mAb, Hy1.2, at 4
C for 1 hr. Bound DNA was detectedPlasmids were digested with BamHI and EcoRI and the resultant
CG50 fragments were purified and their overhanging 5 ends were by scintillation counting of washed cell pellets.
filled with Klenow polymerase in the presence of 5-(3-aminoallyl)
dUTP (aa-dUTP) (Molecular Probes, Eugene, OR). The filled in frag- Acknowledgments
ments included two primary amine-containing bases at the EcoRI
end and one at the BamHI end. Radiolabeled DNA fragments were We thank A. Krieg and R. Weeratna for pMCG-50, E. Paul and M.
made by including –32P-dCTP in the fill-in reaction. All fragments Carroll for 3H9 transgenic mice, A. Haberman, S. Anderson, and J.
were labeled to comparable specific activities. Some DNA fragments William for the VH186.2 and VH186.2L transgenic mice, M. Tessel
were labeled exclusively at the EcoRI end by excluding dCTP and for technical assistance, and R. Corley for helpful discussions and
dGTP from the Klenow reaction. Other fragments were labeled ex- for reviewing the manuscript. This work was supported by grants
clusively at the BamHI end by digestion with BamHI and filling in AR35320 (A.M.R.), PO1-AI36529 (M.J.S.), and AI43603 (M.J.S.) from
the overhang with dNTPs including aa-dUTP, followed by digestion the National Institutes of Health and the Arthritis Foundation
with EcoRI and filling in the overhang in the absence of aa-dUTP. (A.M.R.).
To label with the haptens TNP, NIP or NP, amine–containing DNA
fragments were coupled with succinimidyl ester forms of the hap- Received: July 16, 2003
tens (BioSearch Technologies; Novato, CA). Haptenated DNAs were Revised: October 16, 2003
purified using the Qiaquick PCR purification kit. Mouse genomic Accepted: November 6, 2003
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